Five-year Prostate Cancer Incidence by Stage at Diagnosis
Michigan Male Residents, 1985-2020

Year of Diagnosis	Total	In Situ		Localized		Regional		Distant		Unknown
		Number	Percent	Number	Percent	Number	Percent	Number	Percent	Number	Percent
2016-2020	36,775	7	-	26,393	71.8	5,263	14.3	2,426	6.6	2,686	7.3
2015-2019	35,935	7	-	25,611	71.3	5,247	14.6	2,262	6.3	2,808	7.8
2014-2018	34,124	5	-	24,257	71.1	5,056	14.8	2,055	6.0	2,751	8.1
2013-2017	33,123	4	-	23,696	71.5	4,816	14.5	1,838	5.5	2,769	8.4
2012-2016	32,935	2	-	24,008	72.9	4,674	14.2	1,701	5.2	2,550	7.7
2011-2015	34,886	3	-	26,233	75.2	4,741	13.6	1,576	4.5	2,333	6.7
2010-2014	36,657	4	-	28,085	76.6	4,902	13.4	1,523	4.2	2,143	5.8
2009-2013	38,659	6	-	30,340	78.5	4,909	12.7	1,455	3.8	1,949	5.0
2008-2012	40,634	10	-	32,214	79.3	4,912	12.1	1,411	3.5	2,087	5.1
2007-2011	42,839	12	-	34,457	80.4	4,833	11.3	1,352	3.2	2,185	5.1
2006-2010	42,342	13	-	34,042	80.4	4,549	10.7	1,325	3.1	2,413	5.7
2005-2009	41,725	13	-	33,551	80.4	4,198	10.1	1,255	3.0	2,708	6.5
2004-2008	41,640	17	-	33,168	79.7	4,098	9.8	1,202	2.9	3,155	7.6
2003-2007	41,763	18	-	33,012	79.0	4,004	9.6	1,152	2.8	3,577	8.6
2002-2006	41,923	25	0.1	32,834	78.3	3,968	9.5	1,148	2.7	3,948	9.4
2001-2005	42,462	36	0.1	32,934	77.6	3,886	9.2	1,103	2.6	4,503	10.6
2000-2004	43,568	67	0.2	33,578	77.1	3,862	8.9	1,142	2.6	4,919	11.3
1999-2003	44,234	100	0.2	33,686	76.2	3,830	8.7	1,167	2.6	5,451	12.3
1998-2002	43,757	113	0.3	32,747	74.8	3,802	8.7	1,254	2.9	5,841	13.3
1997-2001	42,306	124	0.3	30,863	73.0	3,762	8.9	1,335	3.2	6,222	14.7
1996-2000	40,612	131	0.3	29,226	72.0	3,738	9.2	1,432	3.5	6,085	15.0
1995-1999	38,983	120	0.3	27,272	70.0	3,831	9.8	1,507	3.9	6,253	16.0
1994-1998	38,028	127	0.3	25,719	67.6	3,898	10.3	1,627	4.3	6,657	17.5
1993-1997	39,310	144	0.4	25,693	65.4	4,398	11.2	1,812	4.6	7,263	18.5
1992-1996	41,548	199	0.5	26,504	63.8	4,882	11.8	2,108	5.1	7,855	18.9
1991-1995	42,743	247	0.6	26,329	61.6	5,233	12.2	2,438	5.7	8,496	19.9
1990-1994	41,904	248	0.6	25,033	59.7	5,207	12.4	2,731	6.5	8,685	20.7
1989-1993	39,199	235	0.6	22,779	58.1	5,002	12.8	3,007	7.7	8,176	20.9
1988-1992	34,663	232	0.7	19,776	57.1	4,433	12.8	3,118	9.0	7,104	20.5
1987-1991	29,160	198	0.7	16,131	55.3	3,604	12.4	3,110	10.7	6,117	21.0
1986-1990	24,540	157	0.6	13,326	54.3	2,888	11.8	3,055	12.4	5,114	20.8
1985-1989	21,757	159	0.7	11,910	54.7	2,385	11.0	2,978	13.7	4,325	19.9

Notes:
In Situ Stage represents the presence of malignant cells within the cell group from which they arose, with no penetration of basement membrane of the tissue and no stromal invasion.
Localized Stage represents invasive cancer confined to the organ of origin or intralumenal extension where specified as an intralumenal extension to immediately contiguous segments of the large bowel.
Regional Stage represents direct extension to adjacent organs or tissues or involvement of the regional lymph nodes.
Distant Stage represents direct continuity to non-adjacent organs, discontinuous metastasis or involvement of the distant lymph nodes.
COVID-19 Pandemic: In 2020, the highly publicized impact of the COVID-19 pandemic on health services and the consequential delays and reductions in cancer screening and diagnosis led to a decline in the 2020 incidence rates for most cancer sites. Because 2020 was a temporary, anomalous year, it can bias estimates such as cancer incidence trends.
Source : Michigan Resident Cancer Incidence File. Updated with cases processed through November 30, 2022. Division for Vital Records & Health Statistics, Michigan Department of Health & Human Services.
Last Updated : April 13, 2023